-
B.S. Pawlyk
Berman–Gund Laboratory for the Study of Retinal Degenerations, Harvard Medical School, Massachusetts Eye and Ear Infirmary, Boston, MA
-
A.J. Smith
Department of Molecular Therapy, Institute of Ophthalmology,University College London, London, United Kingdom
-
P. Buch
Department of Molecular Therapy, Institute of Ophthalmology,University College London, London, United Kingdom
-
M. Adamian
Berman–Gund Laboratory for the Study of Retinal Degenerations, Harvard Medical School, Massachusetts Eye and Ear Infirmary, Boston, MA
-
D.–H. Hong
Berman–Gund Laboratory for the Study of Retinal Degenerations, Harvard Medical School, Massachusetts Eye and Ear Infirmary, Boston, MA
-
M.A. Sandberg
Berman–Gund Laboratory for the Study of Retinal Degenerations, Harvard Medical School, Massachusetts Eye and Ear Infirmary, Boston, MA
-
R.R. Ali
Department of Molecular Therapy, Institute of Ophthalmology,University College London, London, United Kingdom
-
T. Li
Berman–Gund Laboratory for the Study of Retinal Degenerations, Harvard Medical School, Massachusetts Eye and Ear Infirmary, Boston, MA